We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Synbiotics in Cervical Cancer

    The gut microbiota is usually regarded as one of the most crucial aspects in maintaining homeostasis. Probiotic microbes have been proven to come up...
    Sumel Ashique, Ashish Garg, ... Neeraj Mishra in Synbiotics for the Management of Cancer
    Chapter 2023
  2. Biosimilar in Cervical Cancer

    Cervical Cancer is a serious health concern possessing a serious health problem in women. This chapter provides a comprehensive overview of the role...
    Saurabh Morparia, Vasanti Suvarna, Manikanta Murahari in Biosimilars for Cancer Treatment
    Chapter 2024
  3. Immunotherapy for Cervical Cancer

    Cervical cancer is a highly prevalent gynecological malignancy worldwide, and it is associated with high-risk human papillomavirus (HPV) infection....
    Adriana Gutiérrez-Hoya, Arturo Valle-Mendiola, Isabel Soto-Cruz in Handbook of Cancer and Immunology
    Living reference work entry 2023
  4. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways

    Background

    Cancer/testis antigen-45A1 (CT45A1) is overexpressed in various types of cancer but is not expressed in healthy women. The role of CT45A1...

    Mei Meng, Yan Guo, ... Quansheng Zhou in Cellular Oncology
    Article Open access 04 November 2023
  5. Panobinostat (LBH589) combined with AM1241 induces cervical cancer cell apoptosis through autophagy pathway

    Purpose

    The study aims to investigate the apoptotic effects of combining LBH589 and AM1241 (a selective CB2 receptor agonist) on cervical cancer cells...

    Bo Sheng, Wenwen Wang, ... **angdong Qu in BMC Pharmacology and Toxicology
    Article Open access 22 September 2023
  6. The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer

    Background

    Cervical cancer (CC) has poor prognosis and high mortality rate for its metastasis during the disease progression. Epithelial-mesenchymal...

    Mengwen Zhang, **aoling Hong, ... Songling Zhang in Journal of Translational Medicine
    Article Open access 04 July 2023
  7. Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV

    Background

    Persistent high-risk Human papillomavirus (HR-HPV) infections are the main cause of cervical cancer. Cumulative evidence implicates...

    Devamani Chetty-Sebastian, Alain G. Assounga in BMC Cancer
    Article Open access 06 September 2023
  8. Hypoxic tumor cell-derived small extracellular vesicle miR-152-3p promotes cervical cancer radioresistance through KLF15 protein

    Background

    Radiotherapy is widely used in treating cervical cancer patients, however, radioresistance unavoidably occurs and seriously affects the...

    Junying Zhou, Ning**g Lei, ... Lei Chang in Radiation Oncology
    Article Open access 07 November 2023
  9. Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer

    Background

    Cervical cancer is an important public health problem. Conventional colposcopy is inefficient in the diagnosis of cervical lesions and...

    Min Liu, Jianqiao Lu, ... Fang Li in Infectious Agents and Cancer
    Article Open access 26 April 2023
  10. HPV16-miRNAs exert oncogenic effects through enhancers in human cervical cancer

    Background

    Cervical cancer is a human papillomavirus (HPV)-related disease. HPV type 16 (HPV16), which is the predominant cause of cervical cancer,...

    Yunuan Wang, Xueying Wang, ... Qi Lu in Cancer Cell International
    Article Open access 15 May 2024
  11. Understanding the Role of Synbiotics in Prevention and Management of Cervical Cancer

    Cervical cancer appeared to be the fourth most common cancer among women worldwide and Human Papillomavirus (HPV) is identified as the primary causal...
    Anindita Goswami, Suvanjana Ghosh, ... Paramita Mandal in Synbiotics for the Management of Cancer
    Chapter 2023
  12. Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells

    Background

    Tumor resistance is a global challenge for tumor treatment. Cancer stem cells (CSCs) are the main population of tumor cells for drug...

    Hao-Zhe Cao, Wen-Ting Yang, Peng-Sheng Zheng in BMC Cancer
    Article Open access 09 May 2022
  13. Differential proteomics reveals overexpression of ferroptosis-related proteins in cervical cancer tissue

    Cervical cancer, the fourth most common female cancer, is one of the major global health challenges. Because of the high prevalence rate, women are...

    Kumari Binita Chandra, Anil Kumar Tomar, ... Savita Yadav in Journal of Proteins and Proteomics
    Article 12 August 2023
  14. MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3

    In contrast to the decreasing trends in developed countries, the incidence and mortality rates of cervical squamous cell carcinoma in China have...

    Aiqin Zhao, Yunzhi Pan, ... Sai Ma in BMC Cancer
    Article Open access 03 May 2024
  15. miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells

    MicroRNAs have emerged as an important regulator of cell cycle and various other cellular processes. Aberration in microRNAs has been linked with...

    Garima Singh, Sonika Kumari Sharma, Samarendra Kumar Singh in BMC Cancer
    Article Open access 15 July 2022
  16. Anti-Cancer Effects of Disulfiram in Cervical Cancer Cell Lines Are Mediated by Both Autophagy and Apoptosis

    Disulfiram (DSF), which is used to treat alcohol dependence, has been reported to have anticancer effects in various malignant tumors. We studied the...

    W. Zhang, Q. Zhai, ... Y. Li in Bulletin of Experimental Biology and Medicine
    Article 30 March 2022
  17. Highlighting the role of CD44 in cervical cancer progression: immunotherapy’s potential in inhibiting metastasis and chemoresistance

    Cervical cancer affects thousands of women globally with recurring high-risk HPV infections being at the centre of cervical pathology. Oncological...

    Cayleigh de Sousa, Carla Eksteen, ... Anna-Mart Engelbrecht in Immunologic Research
    Article Open access 31 May 2024
  18. Uncharted Potentials of Synbiotics in Treatment of Cervical and Ovarian Cancer

    Cancer is the one of the most prevalent causes of the deaths globally and also a major hindrance to achieve the desired life expectancy in most of...
    Nikhil Mehta, Divya Suares, Saritha Shetty in Synbiotics for the Management of Cancer
    Chapter 2023
  19. NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

    Background

    Radioresistance is the leading cause of death in advanced cervical cancer (CC). Dysregulation of RNA modification has recently emerged as a...

    Min Yu, Mengdong Ni, ... Guihao Ke in Molecular Cancer
    Article Open access 05 July 2024
  20. Ultrasound-based radiomics machine learning models for diagnosing cervical lymph node metastasis in patients with non-small cell lung cancer: a multicentre study

    Background

    Cervical lymph node metastasis (LNM) is an important prognostic factor for patients with non-small cell lung cancer (NSCLC). We aimed to...

    Zhiqiang Deng, **aoling Liu, ... Dong Tian in BMC Cancer
    Article Open access 27 April 2024
Did you find what you were looking for? Share feedback.